RYTM
NASDAQ · Biotechnology
Rhythm Pharmaceuticals Inc
$110.64
+5.62 (+5.35%)
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Price Target
Analyst Price Target
-8.6% upside
Low Target
$80.78
Average Target
$101.09
High Target
$123.16
Current Price
$110.64
Current
$110.64
$110.64
Target
$101.09
$101.09
$80.78
$101.09 avg
$123.16
Scenario Analysis
Bear Case
$80.78
-27.0%
Low target
Base Case
$101.09
-8.6%
Avg target
Bull Case
$123.16
+11.3%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$122.20
-9.5% from high
52-Week Low
$74.50
+48.5% from low
50-Day SMA
$96.15
+15.1% vs SMA
200-Day SMA
$97.01
+14.1% vs SMA
RSI (14)
71.0
Overbought
Target vs 52W High
$101.09
-17.3% vs high
Next Earnings Report
Nov 10, 2026
1d
tomorrow
EPS Est: $-0.73
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |